Personalised Medicine or Targeted Treatments
Personalised medicine is increasingly spoken of, but what does it really mean? NHS England defines it as ‘a move away from a ‘one size fits all’ approach to the treatment and care of patients with a particular condition, to one which uses new approaches to better manage patients’ health and target therapies to achieve the best outcomes in the management of a patient’s disease or predisposition to disease.’
Targeted treatments based on your genetics (or the genetics of your tumour), are not a thing of the future but something that have been around for many years. The NHS test directory sets out all available tests that can be carried out to identify what genetic variations are present in your DNA or your tumour, and therefore which personalised medicines will work for you. More tests are being approved every year and we must ensure that we have the systems in place to allow these tests to be carried out for our patients. At GM Cancer, we are doing this by evaluating all pathways to ensure all eligible patients are receiving the tests and that the results are returned and actioned in an appropriate time frame. To begin with, we are working on the colorectal, thyroid, prostate and HPB pathway.